Breast Cancer Treatment History timeline
-
Benjamin Bell and Jean Louis Petit are the First to Remove the Affected Breast Tissue and Underlying Chest Muscles in Breast Cancer Patients
Then in 1749-1806 the Scottish surgeon Benjamin Bell and the French surgeon Jean Louis Petit were the first one to remove the affected breast... Read more
-
Edwin Smith Buys the Edwin Smith Papyrus, the World's Oldest Surgical Documentation
The earliest known medical document known to man is what is known as the Edwin Smith Papyrus. Edwin Smith was an Egyptologist who bought fragments... Read more
-
Dr. William Steward Halsted Performs the First Mastectomy
Dr. William Steward Halsted was the first to remove a breast in 1882 in the effort to overcome the disease. From 1895 to 1970's 90% of women... Read more
-
The American Cancer Society Founds "Reach to Recovery" to Promote Breast Cancer Treatment and Advocacy
Although doctors have been fighting breast cancer for centuries, it was not until the 20th century that movements to increase breast cancer... Read more
-
FDA Approves Immunex's Thiotepa
Why would this drug be used? Thiotepa is used to treat lymphoma and cancers of the breast, ovary, bladder, and other cancer types. It may also... Read more
-
FDA Approves AstraZeneca's Nolvadex
NOLVADEX is effective in the treatment of metastatic breast cancer in women and men. In premenopausal women with metastatic breast cancer, NOLVADEX... Read more
-
FDA Approves Pharmacia and UpJohn's Adrucil
Treating symptoms of colon, rectum, breast, stomach, and pancreas cancer. Adrucil is an antimetabolite. It works by interfering with the... Read more
-
FDA Approves Bristol Myers Squibb's Taxol
Taxol is one of the newer chemotherapy drugs, and has been around, and in use for some years. It is an extract from the bark and needles of the yew... Read more
-
FDA Approves AstraZeneca's Arimidex
Arimidex (chemical name: anastrozole) is an aromatase inhibitor approved by the U.S. Food and Drug Administration (FDA) to... Read more
-
FDA Approves Sanofi Aventis's Taxotere
Drug Type: Taxotere is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Taxotere is classified as a "plant alkaloid," a... Read more
-
FDA Approves Lilly's Gemzar
Gemzar is indicated in combination with cisplatin for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB)... Read more
-
FDA Approves GTx's Fareston
Fareston is a novel SERM - Selective Estrogen Receptor Modulator (anti estrogen) that is supposedly more powerful than Nolvadex and may have less... Read more
-
FDA Approves Novartis's Femara
This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause.... Read more
-
FDA Approves Lilly's Evista
Evista affects the cycle of bone formation and breakdown in the body, and reduces loss of bone tissue. Evista is used to treat or prevent... Read more
-
FDA Approves Bedford's Adriamycin
Adriamycin is a chemotherapy drug that is administered for the treatment of several types of cancer, including multiple myeloma, bladder cancer,... Read more
-
FDA Approves Hoffmann La Roche's Xeloda
The panel discussed Xeloda in the treatment of patients with locally-advanced or metastatic breast cancer following failure of Bristol-Myers... Read more
-
FDA Approves Genentech's Herceptin
Some breast cancer cells make (overexpress) too many copies of a particular gene known as HER2. The HER2 gene makes a protein known as a HER2... Read more
-
FDA Approves Pfizer's Ellence
Ellence is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body. The exact way it... Read more
-
FDA Approves Pharmacia and UpJohn's Aromasin
Aromasin (Exemestane) is a steroidal suicide aromatase inhibitor, which means that it lowers estrogen production in the body by blocking the... Read more
-
FDA Approves BARR's Trexall
Treating certain types of cancer, severe psoriasis, or rheumatoid arthritis in certain patients. It may be used alone or with other medicines. It... Read more
-
FDA Approves AstraZeneca's Faslodex
Faslodex® (fulvestrant) is an oestrogen receptor antagonist, indicated for the treatment of postmenopausal women with oestrogen receptor-positive,... Read more
-
FDA Approves Genentech's Avastin
Avastin is a cancer medicine that interferes with the growth of cancer cells by blocking the formation and growth of new blood vessels in the tumor... Read more
-
FDA Approves Abraxis's Abraxane
Abraxane® is a chemotherapy drug indicated for the treatment of metastatic breast cancer, in particular patients for whom previous forms of... Read more
-
FDA Approves GlaxoSmithKline's Tykerb
GlaxoSmithKline plc [NYSE: GSK, LSE: GSK] announced today that the United States Food and Drug Administration (FDA) approved TYKERB® (lapatinib),... Read more
-
FDA Approves Bristol-Myers Squibb's Ixempra
Ixempra gained FDA approval as a stand-alone treatment for patients who've failed other chemotherapy and for use with Roche's Xeloda in patients... Read more